Value of the TTM risk score for early prognostication of comatose patients after out-of-hospital cardiac arrest in a Swiss university hospital. by Kägi, Emmanuel et al.
Original article | Published 09 September 2020 | doi:10.4414/smw.2020.20344
Cite this as: Swiss Med Wkly. 2020;150:w20344
Value of the TTM risk score for early
prognostication of comatose patients after
out-of-hospital cardiac arrest in a Swiss
university hospital
Kägi Emmanuela, Weck Anjaab, Iten Manuelaa, Levis Anjaac, Haenggi Matthiasa
a Department of Intensive Care Medicine, Bern University Hospital, Inselspital, University of Bern, Switzerland
b Department of Intensive Care Medicine, Hospital Region Biel/Bienne, Switzerland
c Department of Anaesthesiology and Pain Medicine, Bern University Hospital, Inselspital, University of Bern, Switzerland
Summary
Comatose patients admitted to the intensive care unit
(ICU) after out-of-hospital cardiac arrest frequently die af-
ter withdrawal of life support. Guidelines recommend
scheduling prognostication no sooner than 96 hours after
cardiac arrest, and strict withdrawal criteria leave many
patients waiting for improvement for days without ever
reaching a favourable outcome. In clinical practice, physi-
cians are frequently confronted with vague living wills ex-
pressed by next of kin or an imprecise advance care di-
rective soon after cardiac arrest. Often a decision to admit
a patient to an ICU or limiting ICU treatment in terms of
time or intensity is made early, based on the patient’s pref-
erences. The Target Temperature Management (TTM) risk
score is an imperfect measure that predicts outcome early,
at the time of ICU admission. It was developed on a da-
ta set of 939 patients included in the TTM Trial, a study
in which unconscious patients after cardiac arrest were
randomised into two temperature management arms. Pa-
tient selection in that trial might impede generalisability.
We aimed to validate the TTM risk score with 100 consec-
utive patients treated in our ICU. Although we had differ-
ent survival rates, reflecting a different patient population,
we were able to confirm the score’s albeit imperfect abil-
ity to predict outcome early after cardiac arrest. The sug-
gested cut-off values of 10 and 16 can be used as a ba-
sis for discussion with the family; in particular, a risk score
value below 10 predicts a favourable outcome and might
guide early discussion. As in the original study, the out-
come of an individual patient cannot be predicted. (Clini-
calTrials.gov Identifier: NCT02722460)
Keywords: out-of-hospital cardiac arrest, cardiopul-
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Introduction
Despite advancements in resuscitation practice, the out-
come of patients suffering from cardiac arrest remains poor
to this day. The overall rate of survival to hospital dis-
charge after out-of-hospital resuscitation varies depending
on the population studied (3.1% to 20.4% [1–3]). The rate
of patients with a favourable outcome (defined as return
to baseline or moderate cerebral disability with sufficient
function for independent activities of daily life, and ability
to work in a sheltered environment [4]) is even lower.
Neurological damage results from the ischaemic/hypoxic
injury during the cardiac arrest and the reperfusion injury
after successful resuscitation. Early assessment of the
severity of the oxygen deficiency and the corresponding
neurological impact remains challenging. Prognostication
of unfavourable outcome in comatose patients based on
current guidelines can be made no sooner than 96 hours af-
ter return of spontaneous circulation and, according to our
experience, but also to the literature, only a minority of the
patient outcomes can be predicted with a high degree of
certainty [5, 6]. To keep the time of ambiguity for the pa-
tient’s family as short as possible and to avoid unneces-
sary treatment and thus reduce costs, it is crucial to achieve
an accurate prognostication as soon as possible. Despite
different approaches using a variety of parameters ranging
from basic laboratory test results and clinical signs to the
use of functional magnetic resonance imaging (fMRI) and
electroencephalography (EEG), a validated accurate early
scoring system is still lacking.
In 2017, Martinell et al. [7] developed a scoring system
(the TTM risk score) for early outcome prediction with
10 independent parameters that are usually already avail-
able at the time of patient admission. The parameters com-
prise age, place of cardiac arrest (at home), first monitored
rhythm, no flow time, low flow time, treatment with adren-
aline, presence of pupillary or corneal reflex, pH, Glasgow
Coma Scale (GCS) motor score, and partial pressure of
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carbon dioxide (PaCO2) in the arterial blood gas analysis.
The score ranges from −2 to 35, with higher numbers in-
dicating higher risk of unfavourable outcome. The data-
base used for this score was the patient cohort of the Target
Temperature Management (TTM) Trial [8], which com-
pared two different temperatures for temperature manage-
ment (33 vs 36°C) in 939 patients in 36 ICUs mainly
in Europe (including Geneva, St Gallen, and La Chaux-
de-Fonds, Switzerland), but also in Australia (four ICUs).
Since the TTM followed strict inclusion and exclusion cri-
teria, with a standardised withdrawal of life support pro-
tocol after prognostication, the validity in a general ICU
population of cardiac arrest patients is unknown. With our
study, we aimed to confirm and assess the usefulness of
Martinell and colleagues’ results in a Swiss population suf-
fering from out-of-hospital cardiac arrest outside a clinical
trial. To do this we applied the parameters defined by Mar-
tinell et al. in 100 patients treated after successful resusci-
tation following an out-of-hospital cardiac arrest at the In-
selspital, University Hospital Bern, Switzerland.
Methods
We performed a retrospective cohort study in the first 100
patients (January to mid-September 2016) with a complete
data set of information prospectively collected in a registry
including all patients treated for out-of-hospital cardiac
arrest and admitted to the ICU of the Inselspital Bern.
The cantonal ethics committee (Kantonale Ethikkommis-
sion Bern) approved the registry (KEK BE No. 116/15);
since no intervention was performed the need for informed
consent was waived for those patients who died. Survivors
or their next of kin were informed and consented to the use
of the data collected. The study is registered in ClinicalTri-
als.gov (Identifier: NCT027224609).
Data were manually entered into a RedCap database hosted
by the Clinical Trial Unit of the University of Bern. We
included all patients with cardiopulmonary arrest with re-
turn of spontaneous circulation and a GCS score below 9 at
admission. The main exclusion criteria were neurological
aetiology of cardiopulmonary arrest such as stroke, intrac-
erebral haemorrhage, subarachnoid haemorrhage, SUDEP
(sudden unexpected death in epilepsy) and unwitnessed
cardiac arrest with asystole as the initial rhythm. We sys-
tematically collected data that were available at admission
to the hospital and to the ICU and that were necessary to
calculate the TTM risk score: age, place of cardiac arrest,
initial rhythm at the scene, no-flow time, low-flow time,
administration of adrenaline, bilateral absence of corneal
and pupillary reflexes, GCS motor response, and pH and
partial pressure of carbon dioxide in arterial blood gas
analysis. Missing data (3.3% of all data, predominately the
exact no-flow and low-flow times) were replaced with the
most optimistic value “0”. With these 10 parameters, we
calculated the TTM risk score for each patient (see table
S1 in appendix 1).
For outcome, we chose the Cerebral Performance Category
(CPC), a scale ranging from 1 to 5, with higher scores
meaning worse outcomes (CPC 1 = conscious, alert, able
to work and lead a normal life; 2 = conscious, sufficient
cerebral function for part-time work in a sheltered environ-
ment or independent activities of daily life; 3 = conscious,
dependent on others for daily support, has at least limited
cognition; 4 = unconscious, no cognition; 5 = brain dead).
We used the best CPC score achieved within the first 6
months after cardiopulmonary arrest, and not the 6-month
CPC, to avoid classifying patients with good clinical out-
comes who died a few weeks later for reasons not associ-
ated with the initial cardiac arrest [9].
Outcome was dichotomised into favourable (CPC 1 and 2)
and unfavourable (CPC 3–5), and the receiver operating
characteristic (ROC) curve was constructed. The area un-
der the curve (AUC) was compared with the AUC mea-
sured in the original population described by Martinell [7].
For the ROC curve and the AUC we used Graph Pad Prism
Version 8.2; the comparisons of the AUCs were made ac-
cording to the method proposed by Hanley and McNeil
[10] using the Web application developed by Professor
emeritus Richard Lowry at Vassar College, Poughkeepsie,
N.Y. (http://vassarstats.net/roc_comp.html). Calculation of
sensitivity and specificity were done for two cut-offs of the
TTM risk score, that is, 10 and 16.
Results
We had complete data for 100 of the first 106 patients in
the registry. The AUC of the TTM risk score in our popula-
tion was 0.810 (95% confidence interval [CI] 0.719–0.901,
fig. 1), which is not significantly different from the AUC
of the TTM Trial cohort (0.844, 95% CI 0.842–0.846) (p =
0.47).
Using the TTM risk score cut-offs established by Martinell
[7], we calculated for our patients with a risk score cut-off
at 10 a negative predictive value (NPV) of 0.65, translat-
ing into a likelihood ratio for an unfavourable outcome of
0.22. With a TTM risk score above 16, the positive predic-
tive value (PPV) is 0.93 (tables 1 and 2). Test accuracy is
higher if the lower cut-off of 10 is used (0.77; cut-off of
16: 0.65) (table 3).
Discussion
A comparison of the risk score’s AUC between the original
TTM Trial cohort and our population showed no signif-
icant difference, with a nondirectional p-value of 0.45,
meaning a similar applicability of the TTM risk score with-
in both cohorts. The relatively large 95% CI of our AUC
(0.72–0.90) is due to the smaller cohort used in this study.
Current guidelines, based on available evidence, recom-
mend waiting 72 hours before prognostication of comatose
survivors after cardiac arrest, if pupillary and corneal re-
flexes are absent. If these reflexes are present, an assess-
ment should be made no sooner than 96 hours after cardiac
arrest, by using multiple modalities (clinical evaluation,
EEG, computed tomography / MRI, neuron-specific eno-
lase as a biomarker) [13]. Throughout Europe and the
world, different ethical considerations regarding treatment
and limitations of treatment in patients with cardiac arrest
exist [14]. Many clinicians feel uncomfortable offering a
4- to 5-day course of highly invasive treatment to a pa-
tient whose prognosis is likely to be grim, especially if
the patient has relevant comorbidities or advanced age. Us-
ing clinical experience, the treating physician has to decide
whether a patient with an advance care directive or pre-
viously expressed wishes limiting treatment should be of-
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fered guideline-directed therapy. The published TTM risk
score offers some guidance but is limited by the fact that
study’s inclusion and exclusion criteria created a selection
bias of patients admitted to the ICU, hampering general-
isability. In particular, patients were included in the study
only if full and guideline-directed treatment was offered.
Although not explicitly written, elderly or frail patients are
usually not screened for study purposes because of the high
risk of death in these groups. Patients with a high certain-
ty of death regardless of the group to which they are ran-
domised do not add any evidence from the study’s perspec-
tive and thus are frequently not included. This effect was
seen in our study, where we included all patients and where
we can find a difference in favourable outcomes between
the TTM Trial cohort (52%) and our cohort (29%). This
effect cannot be attributed to worse treatment or prema-
Figure 1: The receiver operating characteristic curves of the Target Temperature Management (TTM) risk score in the Bern cardiac arrest
population admitted to the Inselspital, University Hospital Bern intensive care unit (left). On the right, the ROC curves for a poor outcome at 6
months for other predication scores: the TTM [7] (red), OHCA [11] (blue) and CAHP [12] (green) risk scores. The area under the curve (AUC)
of the TTM score in the Bern population (0.81) is not significantly different from the AUC of the original TTM population [7] (AUC 0.842). The
AUC for the OHCA score is 0.746, and for the CAHP score, it is 0.746. The figure on the right is from Martinell et al, Crit Care 2017;21:96
Table 1: The 10 patient characteristics and circumstantial factors related to outcome.
Parameter Bern cohort Original cohort
CPC 3–5 (UO) CPC 1 and 2 (FO) CPC 3–5 (UO) CPC 1 and 2 (FO)
Number of patients (n) 71 29 440 493
Age (years) 66 (56–75) 66 (49–74) 68 (61–76) 61 (52–69)
CA at home (n) 34 (48%) 6 (21%) 306 (62%) 192 (44%)
First monitored rhythm other than VT/VF (n) 33 (46%) 6 (20%) 169 (34%) 38 (9%)
No flow time (min) 10 (5–15)
n = 63
8 (5–10)
n = 28
2 (0–8)
n = 436
1 (0–3)
n = 491
Low flow time (min) 20 (15–35)
n = 61
10 (5–15)
n = 24
27 (17–40)
n = 439
19 (12–27)
n = 492
Treatment with adrenaline (n) 16 (55%) 63 (87%) 423 (86%) 258 (59%)
Pupillary or corneal reflex (n) 9 (86%)
n = 64
28 (97%)
n = 29
327 (72%)
n = 467
392 (91%)
n = 432
pH 7.13 (7.02–7.25) 7.28 (7.20–7.33) 7.19 (7.05–7.28) 7.27 (7.17–7.32)
GCS motor score 1 (n) 68 (96%) 21 (72%) 316 (65%) 173 (39%)
PaCO2 <4.5 kPa (33.8 mm Hg) (n) 9 (13%) 4 (29%) 66 (14%) 40 (10%)
CA = cardiac arrest; CPC = Cerebral Performance Category; FO = favourable outcome; GCS = Glasgow Coma Scale; UO = unfavourable outcome; VT/VF = ventricular tachy-
cardia / ventricular fibrillation
Data are presented as number (%) or median (25th and 75th percentiles). Poor outcome defined as CPC 3–5 at 3–6 months
Table 2: Number of patients with unfavourable and favourable outcomes depending on the different cut off values 10 and 16.
Outcome CPC 3–5 (UO) CPC 1 and 2 (FO)
TTM risk score cut-off = 10
– Test positive (TTM score >10) 64 16
– Test negative (TTM score ≤10) 7 13
TTM risk score cut-off = 16
– Test positive (TTM score >16) 39 3
– Test negative (TTM score ≤16) 32 26
CPC = Cerebral Performance Category; FO = favourable outcome; TTM = Target Temperature Management; UO = unfavourable outcome
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ture withdrawal of sustained life support alone; for exam-
ple, the Bern cohort in the subsequent TTM 2/TAME Trial
had an overall rate of favourable outcome of >40% (pre-
liminary data, outcome measured with Glasgow Outcome
Scale-Extended).
Our unselected patients admitted to the ICU with a risk
score below 10 had a negative likelihood ratio for an un-
favourable outcome of 0.22, meaning that a favourable
outcome was much more likely than an unfavourable one.
In contrast, in Bern, only 3 of 42 patients (7%) with a
TTM risk score above 16 at admission survived with a
favourable outcome. Keeping in mind that test accuracy is
far from perfect, a patient with a TTM risk score above
16 has a low probability of surviving without major neu-
rological disability. Thus the cut-offs of 10 and 16 make a
reasonable starting point for discussing prognosis with the
family much earlier than guidelines recommend if there are
doubts as to whether the patient should be offered full or
limited treatment.
There are other scoring systems for outcome prediction
based on early available patient and circumstantial factors,
such as the CaRdiac Arrest Survival Score (CRASS) [15],
the CAHP Cardiac Arrest Hospital Prognosis [12] or the
OHCA risk score [11]. As expected, the variables found to
have a significant impact on outcome in all scoring sys-
tems are similar, with age, duration of the no-flow and low-
flow intervals and initial rhythm as main determinants. The
AUCs for outcome prediction are between 0.75 (CAHP
and OHCA) and 0.88 (CRASS), which are in the range of
the TTM score. We chose the TTM score because of its rel-
atively easy applicability compared with the complex cal-
culation of the OHCA score, or the use of nomograms for
the CAHP. The CRASS score was presented only recently
and calculation of the score is complicated, but we expect
online calculators or smartphones apps soon. All the men-
tioned scores have in common that the individual patient’s
outcome cannot be calculation with certainty, only risk cat-
egories.
There are several limitations in both studies. A major lim-
itation in cardiac arrest and prognostication studies is that
the patient’s outcome is at risk of a self-fulfilling prophecy:
if treatment is withdrawn because of a perceived un-
favourable prognosis, the patient will inevitably die and
the perceived bad prognosis will be fulfilled. To overcome
this difficulty, the TTM Trial used a strict protocol-based
withdrawal approach, to reduce errors that could be at-
tributed to early withdrawal of therapy. In our population,
where patients were not subjected to the strict withdrawal
protocol, a more liberal and family-centred approach was
used. If the patient’s presumed desire was a limited ap-
proach, and the family supported the notion that further
treatment was not in the best interest of the patient, we
did not insist on the 96-hour timeframe supported by the
guidelines. For the NPV at the ≤10 cut-off, this leads to a
possible underestimation of the proportion of patients with
a favourable outcome but, in contrast, an overestimation of
PPV in the above-16 group. Compared to the TTM cohort,
ours had fewer patients, which lowers the accuracy of the
test in our population and represents a further limitation.
Patients admitted to the ICU after cardiac arrest who die
after having their life support withdrawn usually do so be-
cause of their unfavourable neurological prognosis [16].
However, there are some patients who die from cardiac
causes before awakening or sedation stop, so conscious-
ness cannot be tested. These patients are classified as hav-
ing an unfavourable outcome, although their neurological
outcome might have been favourable. This inherent mis-
classification will affect any prognostication tool and a cer-
tain degree of uncertainty will always remain.
Another limitation of our results is that almost all patients
arrived at the emergency room already intubated and sedat-
ed, resulting in a GCS motor score of 1 in approximately
90% of this population. Since a GCS motor score of 1 adds
2 points in the TTM risk score, this may shift patients into
a higher risk group. Since the original TTM cohort includ-
ed patients from Europe and Australia, we assume most of
those patients also arrived at the hospital sedated and intu-
bated, but this was not reported.
A limitation in our comparison is that the absence of
corneal and pupillary reflexes was frequently not docu-
mented upon arrival at the emergency room and the ICU,
and was recorded only after the first 24 hours in the ICU.
Thus, the validity of this parameter is limited.
From a practical viewpoint, a further limitation is that more
than a third of the patients in our population had a risk
score between 11 and 16, which represents the “grey zone”
between the given cut-off values. A reasonable approach
for these patients is to use the TTM risk score as a continu-
ous, ordinal scale, with higher scores representing a higher
mortality risk, as represented by the ROC curve.
In conclusion, the results of the TTM risk score test in
our cohort showed a close similarity to the original results
obtained by Martinell et al. [7], especially for risk scores
above 16, despite certain limitations, such as a falsely doc-
umented low GCS motor score or undocumented corneal
and pupillary reflexes upon arrival. With an AUC in the
ROC of 0.81, the TTM risk score cannot predict outcome
at the time of ICU admission with certainty. The proposed
cut-offs at 10 and 16 might guide early patient-centred de-
cisions in patients where a limited treatment approach is
discussed with the family.
Table 3: Measures of diagnostic accuracy.
Variable TTM risk score >10 TTM risk score >16
Sensitivity 0.90 0.55
Specificity 0.45 0.90
Positive predictive value 0.80 0.93
Negative predictive value 0.65 0.45
Positive likelihood ratio 1.63 5.31
Negative likelihood ratio 0.22 0.50
Accuracy 0.77 0.65
TTM = Target Temperature Management
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Appendix 1
Supplementary table
1. Points assigned to categories of the ten independent risk
factors for a poor outcome in the calculation of the Target
Temperature Management risk score. Poor outcome was
defined as Cerebral Performance Category 3–5 at 6 months
after out-of-hospital cardiac arrest. Total score ranged from
−2 to 35.
2. The AUC was 0.84 in the original cohort and 0.81 in the
Bern cohort. This does not allow a definite prognostication
for an individual patient. A score <10 is associated with a
favourable outcome, a score >16 with an unfavourable out-
come.
From:
Kägi E, Weck A, Iten M, Levis A, Haenggi M. Value of the
TTM Risk Score for Early Prognostication of Comatose
Patients after Out-of-Hospital Cardiac Arrest in a Swiss
University Hospital. Swiss Med Wkly 2020;150:w20344.
doi:https://doi.org/10.4414/smw.2020.20344. (For the
Bern cohort.)
and
Martinell L, Nielsen N, Herlitz J, Karlsson T, Horn J,
Wise MP, et al. Early predictors of poor outcome after
out-of-hospital cardiac arrest. Crit Care. 2017;21(1):96.
doi:https://doi.org/10.1186/s13054-017-1677-2. (For the
original cohort.)
Table S1: Target Temperature Management risk score points (range −2 to 35).
Risk factor Categories Points
Age (years) <40 −1
40–44 0
45–49 1
50–54 2
55–59 3
60–64 4
65–69 5
70–74 6
75–79 7
80–84 8
≥85 9
CA at home No 0
Yes 2
First monitored rhythm other than VT/VF No 0
Yes 4
No flow (time from cardiac arrest to start of cardiopulmonary resuscitation in minutes) 0–4 0
5–9 1
10–14 2
≥15 3
Low flow (time in minutes with CPR, until return of spontaneous circulation) 0–5 0
6–15 1
16–30 2
31–60 3
>60 4
Treatment with adrenaline No 0
Yes 2
No pupillary or corneal reflex No 0
Yes 3
pH ≥7.35 −1
7.20–7.34 0
7.05–7.19 1
6.90–7.04 2
<6.90 3
GCS motor score 1 No 0
Yes 2
PaCO2 < 4.5 kPa (<33.8 mm Hg) No 0
Yes 3
Sum
CA = cardiac arrest; GCS = Glasgow Coma Scale; CPR = cardiopulmonary resuscitation; PaCO2 = partial pressure of carbon dioxide in arterial blood; VT/VF = ventricular tachy-
cardia / ventricular fibrillation
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